Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK gets updated hypertension control guidelines:

This article was originally published in Clinica

Executive Summary

The British Hypertension Society has published updated guidelines for the management of hypertension. It comes with a call to improve diagnosis of the condition, following new evidence confirming a persistently high incidence of under-diagnosis, under-treatment and poor rate of blood pressure control in the UK. The guidance features new epidemiological data on the relationship between blood pressure and cardiovascular disease (CVD) risk, confirming the "overpowering significance of systolic blood pressure as a determinant of risk," says the society. The new guidelines (published in full in the Journal of Human Hypertension) replace the sets of recommendations issued in 1989, 1993 and 1999, reiterating existing policy in some areas and extending guidance in others.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT057683

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel